Bank of America Corporation »

Apogee Therapeutics shares owned by Bank of America Corporation

Quarter-by-quarter ownership of Apogee Therapeutics (APGE) shares owned by Bank of America Corporation from 13F filings

Historical chart of Bank of America Corporation investment in Apogee Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Apogee Therapeutics held by Bank of America Corporation consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Apogee Therapeutics by Bank of America Corporation

Quarter filed Position value Share count Share price at filing
2023-12-31 $14M 489k 27.94
2023-09-30 $438k 21k 21.30

More positions owned by Bank of America Corporation

Invesco Qqq Tr Unit Ser 1 (QQQ)
Microsoft Corporation (MSFT)
Apple (AAPL)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Amazon (AMZN)
Vanguard Index Fds Value Etf (VTV)
Ishares Tr Russell 2000 Etf (IWM)
Vanguard Index Fds Growth Etf (VUG)
Ishares Tr Core Msci Eafe (IEFA)
NVIDIA Corporation (NVDA)
Ishares Tr Rus 1000 Grw Etf (IWF)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Tr Rus 1000 Val Etf (IWD)
JPMorgan Chase & Co. (JPM)
Alphabet Cap Stk Cl A (GOOGL)

View all positions for Bank of America Corporation

Top funds holding Apogee Therapeutics

VR Adviser
Fairmount Funds Management
RA Capital Management
Perceptive Advisors
Wellington Management Company
OrbiMed Advisors
Vanguard Group
Franklin Resources
T. Rowe Price Associates
Point72 Asset Management
Braidwell
Bank of America Corporation
Henderson Group
Dr. Jeffrey R. Jay, M.D.
Frazier Life Sciences Management

View all funds holding Apogee Therapeutics